| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| CVS - CVS Health Corp | HOLD | 0 @ USD 80.6 | USD 0 | The current share valuation price of CVS based on adjusted close was USD 80.6. The average price that CVS shares were previous bought at was USD 67.3691. The current market price is 19.6% higher than average price they were purchased at. The value of the holding in CVS has fallen by USD 1,000,731 compared to the previous valuation of CVS Health Corp |
| DVA - DaVita HealthCare Partners Inc | SELL | -40 @ USD 126.56 | USD -5,062 | The ETF sold 40 shares of DVA on 2025-10-29. The shares were previously bought for an average price of USD 145.542. The DaVita HealthCare Partners Inc shares were sold for -13.0% lower than average price of previous purchases. This resulted in an overall loss of USD 759 The average price that the ETF previously sold DVA share for is USD 143.717 which is higher than the selling price of USD 126.56 on 2025-10-29. |
| HSIC - Henry Schein Inc | SELL | -116 @ USD 62.32 | USD -7,229 | The ETF sold 116 shares of HSIC on 2025-10-29. The shares were previously bought for an average price of USD 70.4776. The Henry Schein Inc shares were sold for -11.6% lower than average price of previous purchases. This resulted in an overall loss of USD 946 The average price that the ETF previously sold HSIC share for is USD 69.7809 which is higher than the selling price of USD 62.32 on 2025-10-29. |
| MRNA - Moderna Inc | SELL | -384 @ USD 24.7 | USD -9,485 | The ETF sold 384 shares of MRNA on 2025-10-29. The shares were previously bought for an average price of USD 30.9936. The Moderna Inc shares were sold for -20.3% lower than average price of previous purchases. This resulted in an overall loss of USD 2,417 The average price that the ETF previously sold MRNA share for is USD 38.4297 which is higher than the selling price of USD 24.7 on 2025-10-29. |
| MOH - MOH | SELL | -60 @ USD 160.28 | USD -9,617 | The ETF sold 60 shares of MOH on 2025-10-29. The shares were previously bought for an average price of USD 256.162. The MOH shares were sold for -37.4% lower than average price of previous purchases. This resulted in an overall loss of USD 5,753 The average price that the ETF previously sold MOH share for is USD 296.963 which is higher than the selling price of USD 160.28 on 2025-10-29. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -60 @ USD 160.28 | USD -9,617 | The ETF sold 60 shares of MOH on 2025-10-29. The shares were previously bought for an average price of USD 256.162. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -37.4% lower than average price of previous purchases. This resulted in an overall loss of USD 5,753 The average price that the ETF previously sold MOH share for is USD 296.963 which is higher than the selling price of USD 160.28 on 2025-10-29. |
| CRL - Creightons Plc | SELL | -54 @ USD 180.15 | USD -9,728 | The ETF sold 54 shares of CRL on 2025-10-29. The shares were previously bought for an average price of USD 165.311. The Creightons Plc shares were sold for 9.0% higher than average price of previous purchases. This sale made a profit of USD 801 The average price that the ETF previously sold CRL share for is USD 174.653 so the ETF has sold 54 shares on 2025-10-29 at a higher price than the previous selling average. |
| ALGN - Align Technology Inc | SELL | -74 @ USD 131.91 | USD -9,761 | The ETF sold 74 shares of ALGN on 2025-10-29. The shares were previously bought for an average price of USD 171.35. The Align Technology Inc shares were sold for -23.0% lower than average price of previous purchases. This resulted in an overall loss of USD 2,919 The average price that the ETF previously sold ALGN share for is USD 204.019 which is higher than the selling price of USD 131.91 on 2025-10-29. |
| TECH - Bio-Techne Corp | SELL | -174 @ USD 62.02 | USD -10,791 | The ETF sold 174 shares of TECH on 2025-10-29. The shares were previously bought for an average price of USD 60.602. The Bio-Techne Corp shares were sold for 2.3% higher than average price of previous purchases. This sale made a profit of USD 247 The average price that the ETF previously sold TECH share for is USD 66.2085 which is higher than the selling price of USD 62.02 on 2025-10-29. |
| SOLV - Solventum Corp. | SELL | -162 @ USD 69.78 | USD -11,304 | The ETF sold 162 shares of SOLV on 2025-10-29. The shares were previously bought for an average price of USD 72.9829. The Solventum Corp. shares were sold for -4.4% lower than average price of previous purchases. This resulted in an overall loss of USD 519 The average price that the ETF previously sold SOLV share for is USD 71.1902 which is higher than the selling price of USD 69.78 on 2025-10-29. |
| RVTY - Revvity Inc. | SELL | -130 @ USD 95.3 | USD -12,389 | The ETF sold 130 shares of RVTY on 2025-10-29. The shares were previously bought for an average price of USD 104.013. The Revvity Inc. shares were sold for -8.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,133 The average price that the ETF previously sold RVTY share for is USD 108.402 which is higher than the selling price of USD 95.3 on 2025-10-29. |
| BAX - Baxter International Inc | SELL | -574 @ USD 22.42 | USD -12,869 | The ETF sold 574 shares of BAX on 2025-10-29. The shares were previously bought for an average price of USD 29.5425. The Baxter International Inc shares were sold for -24.1% lower than average price of previous purchases. This resulted in an overall loss of USD 4,088 The average price that the ETF previously sold BAX share for is USD 31.6283 which is higher than the selling price of USD 22.42 on 2025-10-29. |
| VTRS - Viatris Inc | SELL | -1,290 @ USD 10.27 | USD -13,248 | The ETF sold 1290 shares of VTRS on 2025-10-29. The shares were previously bought for an average price of USD 10.2659. The Viatris Inc shares were sold for 0.0% higher than average price of previous purchases. This sale made a profit of USD 5 The average price that the ETF previously sold VTRS share for is USD 11.1885 which is higher than the selling price of USD 10.27 on 2025-10-29. |
| UHS - Universal Health Services Inc | SELL | -62 @ USD 225.3 | USD -13,969 | The ETF sold 62 shares of UHS on 2025-10-29. The shares were previously bought for an average price of USD 187.923. The Universal Health Services Inc shares were sold for 19.9% higher than average price of previous purchases. This sale made a profit of USD 2,317 The average price that the ETF previously sold UHS share for is USD 190.132 so the ETF has sold 62 shares on 2025-10-29 at a higher price than the previous selling average. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -222 @ USD 69.58 | USD -15,447 | The ETF sold 222 shares of COO on 2025-10-29. The shares were previously bought for an average price of USD 81.9241. The The Cooper Companies, Inc. Common Stock shares were sold for -15.1% lower than average price of previous purchases. This resulted in an overall loss of USD 2,740 The average price that the ETF previously sold COO share for is USD 90.2788 which is higher than the selling price of USD 69.58 on 2025-10-29. |
| INCY - Incyte Corporation | SELL | -184 @ USD 90.18 | USD -16,593 | The ETF sold 184 shares of INCY on 2025-10-29. The shares were previously bought for an average price of USD 75.8377. The Incyte Corporation shares were sold for 18.9% higher than average price of previous purchases. This sale made a profit of USD 2,639 The average price that the ETF previously sold INCY share for is USD 72.2053 so the ETF has sold 184 shares on 2025-10-29 at a higher price than the previous selling average. |
| HOLX - Hologic Inc | SELL | -248 @ USD 73.98 | USD -18,347 | The ETF sold 248 shares of HOLX on 2025-10-29. The shares were previously bought for an average price of USD 67.0188. The Hologic Inc shares were sold for 10.4% higher than average price of previous purchases. This sale made a profit of USD 1,726 The average price that the ETF previously sold HOLX share for is USD 70.6187 so the ETF has sold 248 shares on 2025-10-29 at a higher price than the previous selling average. |
| CNC - Concurrent Technologies Plc | SELL | -522 @ USD 37.34 | USD -19,491 | The ETF sold 522 shares of CNC on 2025-10-29. The shares were previously bought for an average price of USD 48.9054. The Concurrent Technologies Plc shares were sold for -23.6% lower than average price of previous purchases. This resulted in an overall loss of USD 6,037 The average price that the ETF previously sold CNC share for is USD 53.6709 which is higher than the selling price of USD 37.34 on 2025-10-29. |
| DGX - Quest Diagnostics Incorporated | SELL | -124 @ USD 174.78 | USD -21,673 | The ETF sold 124 shares of DGX on 2025-10-29. The shares were previously bought for an average price of USD 172.873. The Quest Diagnostics Incorporated shares were sold for 1.1% higher than average price of previous purchases. This sale made a profit of USD 236 The average price that the ETF previously sold DGX share for is USD 163.815 so the ETF has sold 124 shares on 2025-10-29 at a higher price than the previous selling average. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -222 @ USD 99.71 | USD -22,136 | The ETF sold 222 shares of ZBH on 2025-10-29. The shares were previously bought for an average price of USD 103.524. The Zimmer Biomet Holdings Inc shares were sold for -3.7% lower than average price of previous purchases. This resulted in an overall loss of USD 847 The average price that the ETF previously sold ZBH share for is USD 104.41 which is higher than the selling price of USD 99.71 on 2025-10-29. |
| WST - West Pharmaceutical Services Inc | SELL | -78 @ USD 284.86 | USD -22,219 | The ETF sold 78 shares of WST on 2025-10-29. The shares were previously bought for an average price of USD 252.773. The West Pharmaceutical Services Inc shares were sold for 12.7% higher than average price of previous purchases. This sale made a profit of USD 2,503 The average price that the ETF previously sold WST share for is USD 286.138 which is higher than the selling price of USD 284.86 on 2025-10-29. |
| WAT - Waters Corporation | SELL | -66 @ USD 343.47 | USD -22,669 | The ETF sold 66 shares of WAT on 2025-10-29. The shares were previously bought for an average price of USD 343.972. The Waters Corporation shares were sold for -0.1% lower than average price of previous purchases. This resulted in an overall loss of USD 33 The average price that the ETF previously sold WAT share for is USD 363.3 which is higher than the selling price of USD 343.47 on 2025-10-29. |
| WAT - MULETFWATIMETFP | SELL | -66 @ USD 343.47 | USD -22,669 | The ETF sold 66 shares of WAT on 2025-10-29. The shares were previously bought for an average price of USD 343.972. The MULETFWATIMETFP shares were sold for -0.1% lower than average price of previous purchases. This resulted in an overall loss of USD 33 The average price that the ETF previously sold WAT share for is USD 363.3 which is higher than the selling price of USD 343.47 on 2025-10-29. |
| LH - Laboratory Corporation of America Holdings | SELL | -92 @ USD 248.14 | USD -22,829 | The ETF sold 92 shares of LH on 2025-10-29. The shares were previously bought for an average price of USD 255.808. The Laboratory Corporation of America Holdings shares were sold for -3.0% lower than average price of previous purchases. This resulted in an overall loss of USD 705 The average price that the ETF previously sold LH share for is USD 241.515 so the ETF has sold 92 shares on 2025-10-29 at a higher price than the previous selling average. |
| BIIB - Biogen Inc | SELL | -162 @ USD 147.86 | USD -23,953 | The ETF sold 162 shares of BIIB on 2025-10-29. The shares were previously bought for an average price of USD 141.312. The Biogen Inc shares were sold for 4.6% higher than average price of previous purchases. This sale made a profit of USD 1,061 The average price that the ETF previously sold BIIB share for is USD 151.406 which is higher than the selling price of USD 147.86 on 2025-10-29. |
| PODD - Insulet Corporation | SELL | -76 @ USD 316.17 | USD -24,029 | The ETF sold 76 shares of PODD on 2025-10-29. The shares were previously bought for an average price of USD 291.515. The Insulet Corporation shares were sold for 8.5% higher than average price of previous purchases. This sale made a profit of USD 1,874 The average price that the ETF previously sold PODD share for is USD 272.865 so the ETF has sold 76 shares on 2025-10-29 at a higher price than the previous selling average. |
| STE - STERIS plc | SELL | -110 @ USD 236.79 | USD -26,047 | The ETF sold 110 shares of STE on 2025-10-29. The shares were previously bought for an average price of USD 230.678. The STERIS plc shares were sold for 2.6% higher than average price of previous purchases. This sale made a profit of USD 672 The average price that the ETF previously sold STE share for is USD 220.687 so the ETF has sold 110 shares on 2025-10-29 at a higher price than the previous selling average. |
| DXCM - DexCom Inc | SELL | -438 @ USD 68.18 | USD -29,863 | The ETF sold 438 shares of DXCM on 2025-10-29. The shares were previously bought for an average price of USD 77.3681. The DexCom Inc shares were sold for -11.9% lower than average price of previous purchases. This resulted in an overall loss of USD 4,024 The average price that the ETF previously sold DXCM share for is USD 77.3396 which is higher than the selling price of USD 68.18 on 2025-10-29. |
| MTD - Mettler-Toledo International Inc | SELL | -22 @ USD 1394.17 | USD -30,672 | The ETF sold 22 shares of MTD on 2025-10-29. The shares were previously bought for an average price of USD 1259.68. The Mettler-Toledo International Inc shares were sold for 10.7% higher than average price of previous purchases. This sale made a profit of USD 2,959 The average price that the ETF previously sold MTD share for is USD 1231.16 so the ETF has sold 22 shares on 2025-10-29 at a higher price than the previous selling average. |
| MTD - AMUNDI EUR GOV 710 | SELL | -22 @ USD 1394.17 | USD -30,672 | The ETF sold 22 shares of MTD on 2025-10-29. The shares were previously bought for an average price of USD 1259.68. The AMUNDI EUR GOV 710 shares were sold for 10.7% higher than average price of previous purchases. This sale made a profit of USD 2,959 The average price that the ETF previously sold MTD share for is USD 1231.16 so the ETF has sold 22 shares on 2025-10-29 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -134 @ USD 292.67 | USD -39,218 | The ETF sold 134 shares of HUM on 2025-10-29. The shares were previously bought for an average price of USD 267.938. The Hummingbird Resources PLC shares were sold for 9.2% higher than average price of previous purchases. This sale made a profit of USD 3,314 The average price that the ETF previously sold HUM share for is USD 268.296 so the ETF has sold 134 shares on 2025-10-29 at a higher price than the previous selling average. |
| HUM - Humana Inc | SELL | -134 @ USD 292.67 | USD -39,218 | The ETF sold 134 shares of HUM on 2025-10-29. The shares were previously bought for an average price of USD 267.938. The Humana Inc shares were sold for 9.2% higher than average price of previous purchases. This sale made a profit of USD 3,314 The average price that the ETF previously sold HUM share for is USD 268.296 so the ETF has sold 134 shares on 2025-10-29 at a higher price than the previous selling average. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -510 @ USD 77.38 | USD -39,464 | The ETF sold 510 shares of GEHC on 2025-10-29. The shares were previously bought for an average price of USD 79.3186. The GE HealthCare Technologies Inc. shares were sold for -2.4% lower than average price of previous purchases. This resulted in an overall loss of USD 989 The average price that the ETF previously sold GEHC share for is USD 79.287 which is higher than the selling price of USD 77.38 on 2025-10-29. |
| IQV - IQVIA Holdings Inc | SELL | -188 @ USD 217.83 | USD -40,952 | The ETF sold 188 shares of IQV on 2025-10-29. The shares were previously bought for an average price of USD 188.611. The IQVIA Holdings Inc shares were sold for 15.5% higher than average price of previous purchases. This sale made a profit of USD 5,493 The average price that the ETF previously sold IQV share for is USD 188.097 so the ETF has sold 188 shares on 2025-10-29 at a higher price than the previous selling average. |
| RMD - ResMed Inc | SELL | -164 @ USD 253.62 | USD -41,594 | The ETF sold 164 shares of RMD on 2025-10-29. The shares were previously bought for an average price of USD 251.645. The ResMed Inc shares were sold for 0.8% higher than average price of previous purchases. This sale made a profit of USD 324 The average price that the ETF previously sold RMD share for is USD 243.702 so the ETF has sold 164 shares on 2025-10-29 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -264 @ USD 164.47 | USD -43,420 | The ETF sold 264 shares of CAH on 2025-10-29. The shares were previously bought for an average price of USD 139.681. The Cardinal Health Inc shares were sold for 17.7% higher than average price of previous purchases. This sale made a profit of USD 6,544 The average price that the ETF previously sold CAH share for is USD 132.872 so the ETF has sold 264 shares on 2025-10-29 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -318 @ USD 143.2 | USD -45,538 | The ETF sold 318 shares of A on 2025-10-29. The shares were previously bought for an average price of USD 126.829. The Agilent Technologies Inc shares were sold for 12.9% higher than average price of previous purchases. This sale made a profit of USD 5,206 The average price that the ETF previously sold A share for is USD 129.845 so the ETF has sold 318 shares on 2025-10-29 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -658 @ USD 82.69 | USD -54,410 | The ETF sold 658 shares of EW on 2025-10-29. The shares were previously bought for an average price of USD 73.5806. The Edwards Lifesciences Corp shares were sold for 12.4% higher than average price of previous purchases. This sale made a profit of USD 5,994 The average price that the ETF previously sold EW share for is USD 71.7141 so the ETF has sold 658 shares on 2025-10-29 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -88 @ USD 627.66 | USD -55,234 | The ETF sold 88 shares of IDXX on 2025-10-29. The shares were previously bought for an average price of USD 523.201. The IDEXX Laboratories Inc shares were sold for 20.0% higher than average price of previous purchases. This sale made a profit of USD 9,192 The average price that the ETF previously sold IDXX share for is USD 459.417 so the ETF has sold 88 shares on 2025-10-29 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -320 @ USD 181.52 | USD -58,086 | The ETF sold 320 shares of BDX on 2025-10-29. The shares were previously bought for an average price of USD 209.047. The Becton Dickinson and Company shares were sold for -13.2% lower than average price of previous purchases. This resulted in an overall loss of USD 8,809 The average price that the ETF previously sold BDX share for is USD 211.665 which is higher than the selling price of USD 181.52 on 2025-10-29. |
| ZTS - Zoetis Inc | SELL | -496 @ USD 143.94 | USD -71,394 | The ETF sold 496 shares of ZTS on 2025-10-29. The shares were previously bought for an average price of USD 159.7. The Zoetis Inc shares were sold for -9.9% lower than average price of previous purchases. This resulted in an overall loss of USD 7,817 The average price that the ETF previously sold ZTS share for is USD 167.907 which is higher than the selling price of USD 143.94 on 2025-10-29. |
| COR - Cencora Inc. | SELL | -216 @ USD 333.17 | USD -71,965 | The ETF sold 216 shares of COR on 2025-10-29. The shares were previously bought for an average price of USD 290.038. The Cencora Inc. shares were sold for 14.9% higher than average price of previous purchases. This sale made a profit of USD 9,317 The average price that the ETF previously sold COR share for is USD 259.111 so the ETF has sold 216 shares on 2025-10-29 at a higher price than the previous selling average. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -114 @ USD 652.91 | USD -74,432 | The ETF sold 114 shares of REGN on 2025-10-29. The shares were previously bought for an average price of USD 643.204. The Regeneron Pharmaceuticals Inc shares were sold for 1.5% higher than average price of previous purchases. This sale made a profit of USD 1,106 The average price that the ETF previously sold REGN share for is USD 689.029 which is higher than the selling price of USD 652.91 on 2025-10-29. |
| ELV - Elevance Health Inc | SELL | -250 @ USD 336.36 | USD -84,090 | The ETF sold 250 shares of ELV on 2025-10-29. The shares were previously bought for an average price of USD 375.134. The Elevance Health Inc shares were sold for -10.3% lower than average price of previous purchases. This resulted in an overall loss of USD 9,694 The average price that the ETF previously sold ELV share for is USD 391.429 which is higher than the selling price of USD 336.36 on 2025-10-29. |
| ELV - Elevance Health Inc | SELL | -250 @ USD 336.36 | USD -84,090 | The ETF sold 250 shares of ELV on 2025-10-29. The shares were previously bought for an average price of USD 375.134. The Elevance Health Inc shares were sold for -10.3% lower than average price of previous purchases. This resulted in an overall loss of USD 9,694 The average price that the ETF previously sold ELV share for is USD 391.429 which is higher than the selling price of USD 336.36 on 2025-10-29. |
| HCA - HCA Holdings Inc | SELL | -182 @ USD 468.4 | USD -85,249 | The ETF sold 182 shares of HCA on 2025-10-29. The shares were previously bought for an average price of USD 366.163. The HCA Holdings Inc shares were sold for 27.9% higher than average price of previous purchases. This sale made a profit of USD 18,607 The average price that the ETF previously sold HCA share for is USD 352.219 so the ETF has sold 182 shares on 2025-10-29 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -298 @ USD 299.12 | USD -89,138 | The ETF sold 298 shares of CI on 2025-10-29. The shares were previously bought for an average price of USD 308.063. The Cigna Corp shares were sold for -2.9% lower than average price of previous purchases. This resulted in an overall loss of USD 2,665 The average price that the ETF previously sold CI share for is USD 312.385 which is higher than the selling price of USD 299.12 on 2025-10-29. |
| BMY - Bloomsbury Publishing Plc | SELL | -2,276 @ USD 42.6 | USD -96,958 | The ETF sold 2276 shares of BMY on 2025-10-29. The shares were previously bought for an average price of USD 52.2194. The Bloomsbury Publishing Plc shares were sold for -18.4% lower than average price of previous purchases. This resulted in an overall loss of USD 21,894 The average price that the ETF previously sold BMY share for is USD 54.1357 which is higher than the selling price of USD 42.6 on 2025-10-29. |
| MCK - McKesson Corporation | SELL | -138 @ USD 807.63 | USD -111,453 | The ETF sold 138 shares of MCK on 2025-10-29. The shares were previously bought for an average price of USD 668.795. The McKesson Corporation shares were sold for 20.8% higher than average price of previous purchases. This sale made a profit of USD 19,159 The average price that the ETF previously sold MCK share for is USD 632.778 so the ETF has sold 138 shares on 2025-10-29 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -286 @ USD 417.21 | USD -119,322 | The ETF sold 286 shares of VRTX on 2025-10-29. The shares were previously bought for an average price of USD 444.154. The Vertex Pharmaceuticals Inc shares were sold for -6.1% lower than average price of previous purchases. This resulted in an overall loss of USD 7,706 The average price that the ETF previously sold VRTX share for is USD 460.799 which is higher than the selling price of USD 417.21 on 2025-10-29. |
| MDT - Medtronic PLC | SELL | -1,434 @ USD 91.73 | USD -131,541 | The ETF sold 1434 shares of MDT on 2025-10-29. The shares were previously bought for an average price of USD 90.3357. The Medtronic PLC shares were sold for 1.5% higher than average price of previous purchases. This sale made a profit of USD 1,999 The average price that the ETF previously sold MDT share for is USD 86.1518 so the ETF has sold 1434 shares on 2025-10-29 at a higher price than the previous selling average. |
| SYK - Stryker Corporation | SELL | -384 @ USD 369.59 | USD -141,923 | The ETF sold 384 shares of SYK on 2025-10-29. The shares were previously bought for an average price of USD 378.272. The Stryker Corporation shares were sold for -2.3% lower than average price of previous purchases. This resulted in an overall loss of USD 3,334 The average price that the ETF previously sold SYK share for is USD 377.673 which is higher than the selling price of USD 369.59 on 2025-10-29. |
| DHR - Danaher Corporation | SELL | -710 @ USD 214.01 | USD -151,947 | The ETF sold 710 shares of DHR on 2025-10-29. The shares were previously bought for an average price of USD 211.885. The Danaher Corporation shares were sold for 1.0% higher than average price of previous purchases. This sale made a profit of USD 1,509 The average price that the ETF previously sold DHR share for is USD 223.561 which is higher than the selling price of USD 214.01 on 2025-10-29. |
| DHR - Danaher Corporation | SELL | -710 @ USD 214.01 | USD -151,947 | The ETF sold 710 shares of DHR on 2025-10-29. The shares were previously bought for an average price of USD 211.885. The Danaher Corporation shares were sold for 1.0% higher than average price of previous purchases. This sale made a profit of USD 1,509 The average price that the ETF previously sold DHR share for is USD 223.561 which is higher than the selling price of USD 214.01 on 2025-10-29. |
| PFE - Pfizer Inc | SELL | -6,372 @ USD 24.29 | USD -154,776 | The ETF sold 6372 shares of PFE on 2025-10-29. The shares were previously bought for an average price of USD 25.3347. The Pfizer Inc shares were sold for -4.1% lower than average price of previous purchases. This resulted in an overall loss of USD 6,657 The average price that the ETF previously sold PFE share for is USD 25.5824 which is higher than the selling price of USD 24.29 on 2025-10-29. |
| GILD - Guild Esports Plc | SELL | -1,388 @ USD 118.5 | USD -164,478 | The ETF sold 1388 shares of GILD on 2025-10-29. The shares were previously bought for an average price of USD 108.796. The Guild Esports Plc shares were sold for 8.9% higher than average price of previous purchases. This sale made a profit of USD 13,469 The average price that the ETF previously sold GILD share for is USD 98.479 so the ETF has sold 1388 shares on 2025-10-29 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -1,658 @ USD 100.3 | USD -166,297 | The ETF sold 1658 shares of BSX on 2025-10-29. The shares were previously bought for an average price of USD 99.9352. The Boston Scientific Corporation shares were sold for 0.4% higher than average price of previous purchases. This sale made a profit of USD 605 The average price that the ETF previously sold BSX share for is USD 93.6149 so the ETF has sold 1658 shares on 2025-10-29 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -1,658 @ USD 100.3 | USD -166,297 | The ETF sold 1658 shares of BSX on 2025-10-29. The shares were previously bought for an average price of USD 99.9352. The MULSTRXSSXIMETFP shares were sold for 0.4% higher than average price of previous purchases. This sale made a profit of USD 605 The average price that the ETF previously sold BSX share for is USD 93.6149 so the ETF has sold 1658 shares on 2025-10-29 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -600 @ USD 291.77 | USD -175,062 | The ETF sold 600 shares of AMGN on 2025-10-29. The shares were previously bought for an average price of USD 297.866. The Amgen Inc shares were sold for -2.0% lower than average price of previous purchases. This resulted in an overall loss of USD 3,658 The average price that the ETF previously sold AMGN share for is USD 288.85 so the ETF has sold 600 shares on 2025-10-29 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -400 @ USD 537.59 | USD -215,036 | The ETF sold 400 shares of ISRG on 2025-10-29. The shares were previously bought for an average price of USD 509.395. The Intuitive Surgical Inc shares were sold for 5.5% higher than average price of previous purchases. This sale made a profit of USD 11,278 The average price that the ETF previously sold ISRG share for is USD 527.804 so the ETF has sold 400 shares on 2025-10-29 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -422 @ USD 558.31 | USD -235,607 | The ETF sold 422 shares of TMO on 2025-10-29. The shares were previously bought for an average price of USD 504.197. The Time Out Group plc shares were sold for 10.7% higher than average price of previous purchases. This sale made a profit of USD 22,836 The average price that the ETF previously sold TMO share for is USD 496.51 so the ETF has sold 422 shares on 2025-10-29 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -2,796 @ USD 86.58 | USD -242,078 | The ETF sold 2796 shares of MRK on 2025-10-29. The shares were previously bought for an average price of USD 88.1518. The Marks Electrical Group PLC shares were sold for -1.8% lower than average price of previous purchases. This resulted in an overall loss of USD 4,395 The average price that the ETF previously sold MRK share for is USD 94.1591 which is higher than the selling price of USD 86.58 on 2025-10-29. |
| MRK - Merck & Company Inc | SELL | -2,796 @ USD 86.58 | USD -242,078 | The ETF sold 2796 shares of MRK on 2025-10-29. The shares were previously bought for an average price of USD 88.1518. The Merck & Company Inc shares were sold for -1.8% lower than average price of previous purchases. This resulted in an overall loss of USD 4,395 The average price that the ETF previously sold MRK share for is USD 94.1591 which is higher than the selling price of USD 86.58 on 2025-10-29. |
| ABT - Abbott Laboratories | SELL | -1,948 @ USD 124.43 | USD -242,390 | The ETF sold 1948 shares of ABT on 2025-10-29. The shares were previously bought for an average price of USD 129.177. The Abbott Laboratories shares were sold for -3.7% lower than average price of previous purchases. This resulted in an overall loss of USD 9,247 The average price that the ETF previously sold ABT share for is USD 121.655 so the ETF has sold 1948 shares on 2025-10-29 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -1,008 @ USD 355.26 | USD -358,102 | The ETF sold 1008 shares of UNH on 2025-10-29. The shares were previously bought for an average price of USD 432.235. The UnitedHealth Group Incorporated shares were sold for -17.8% lower than average price of previous purchases. This resulted in an overall loss of USD 77,591 The average price that the ETF previously sold UNH share for is USD 491.288 which is higher than the selling price of USD 355.26 on 2025-10-29. |
| ABBV - AbbVie Inc | SELL | -1,962 @ USD 225.14 | USD -441,725 | The ETF sold 1962 shares of ABBV on 2025-10-29. The shares were previously bought for an average price of USD 201.288. The AbbVie Inc shares were sold for 11.8% higher than average price of previous purchases. This sale made a profit of USD 46,798 The average price that the ETF previously sold ABBV share for is USD 187.022 so the ETF has sold 1962 shares on 2025-10-29 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -2,674 @ USD 186.6 | USD -498,968 | The ETF sold 2674 shares of JNJ on 2025-10-29. The shares were previously bought for an average price of USD 165.991. The Johnson & Johnson shares were sold for 12.4% higher than average price of previous purchases. This sale made a profit of USD 55,108 The average price that the ETF previously sold JNJ share for is USD 154.231 so the ETF has sold 2674 shares on 2025-10-29 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -878 @ USD 813.53 | USD -714,279 | The ETF sold 878 shares of LLY on 2025-10-29. The shares were previously bought for an average price of USD 795.714. The Eli Lilly and Company shares were sold for 2.2% higher than average price of previous purchases. This sale made a profit of USD 15,642 The average price that the ETF previously sold LLY share for is USD 792.273 so the ETF has sold 878 shares on 2025-10-29 at a higher price than the previous selling average. |